Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-21-017979
Date:2021-05-24
Issuer: APELLIS PHARMACEUTICALS, INC. (APLS)
Original Submission Date:

Reporting Person:

DESCHATELETS PASCAL
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR WALTHAM, MA 02451

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-24 M 6,250 a $2.67 875,837 direct
COMMON STOCK 2021-05-24 S 6,250 d $47.40 869,587 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.67 2021-05-24 deemed execution date M 6,250 (d) 2023-12-05 common stock 6,250 $2.67 375,249 direct
Footnotes
IDfootnote
f1 this is a scheduled exercise from 10b5-1 trading plan.
f2 this stock option was granted on 12/5/2013 and is fully vested.

Elevate your investments